Skip to main content
Journal cover image

Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.

Publication ,  Journal Article
Huang, B; Sollee, J; Luo, Y-H; Reddy, A; Zhong, Z; Wu, J; Mammarappallil, J; Healey, T; Cheng, G; Azzoli, C; Korogodsky, D; Zhang, P; Feng, X ...
Published in: EBioMedicine
August 2022

BACKGROUND: Pre-treatment FDG-PET/CT scans were analyzed with machine learning to predict progression of lung malignancies and overall survival (OS). METHODS: A retrospective review across three institutions identified patients with a pre-procedure FDG-PET/CT and an associated malignancy diagnosis. Lesions were manually and automatically segmented, and convolutional neural networks (CNNs) were trained using FDG-PET/CT inputs to predict malignancy progression. Performance was evaluated using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. Image features were extracted from CNNs and by radiomics feature extraction, and random survival forests (RSF) were constructed to predict OS. Concordance index (C-index) and integrated brier score (IBS) were used to evaluate OS prediction. FINDINGS: 1168 nodules (n=965 patients) were identified. 792 nodules had progression and 376 were progression-free. The most common malignancies were adenocarcinoma (n=740) and squamous cell carcinoma (n=179). For progression risk, the PET+CT ensemble model with manual segmentation (accuracy=0.790, AUC=0.876) performed similarly to the CT only (accuracy=0.723, AUC=0.888) and better compared to the PET only (accuracy=0.664, AUC=0.669) models. For OS prediction with deep learning features, the PET+CT+clinical RSF ensemble model (C-index=0.737) performed similarly to the CT only (C-index=0.730) and better than the PET only (C-index=0.595), and clinical only (C-index=0.595) models. RSF models constructed with radiomics features had comparable performance to those with CNN features. INTERPRETATION: CNNs trained using pre-treatment FDG-PET/CT and extracted performed well in predicting lung malignancy progression and OS. OS prediction performance with CNN features was comparable to a radiomics approach. The prognostic models could inform treatment options and improve patient care. FUNDING: NIH NHLBI training grant (5T35HL094308-12, John Sollee).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

EBioMedicine

DOI

EISSN

2352-3964

Publication Date

August 2022

Volume

82

Start / End Page

104127

Location

Netherlands

Related Subject Headings

  • Positron-Emission Tomography
  • Positron Emission Tomography Computed Tomography
  • Machine Learning
  • Lung Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Huang, B., Sollee, J., Luo, Y.-H., Reddy, A., Zhong, Z., Wu, J., … Bai, H. X. (2022). Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT. EBioMedicine, 82, 104127. https://doi.org/10.1016/j.ebiom.2022.104127
Huang, Brian, John Sollee, Yong-Heng Luo, Ashwin Reddy, Zhusi Zhong, Jing Wu, Joseph Mammarappallil, et al. “Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.EBioMedicine 82 (August 2022): 104127. https://doi.org/10.1016/j.ebiom.2022.104127.
Huang B, Sollee J, Luo Y-H, Reddy A, Zhong Z, Wu J, et al. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT. EBioMedicine. 2022 Aug;82:104127.
Huang, Brian, et al. “Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.EBioMedicine, vol. 82, Aug. 2022, p. 104127. Pubmed, doi:10.1016/j.ebiom.2022.104127.
Huang B, Sollee J, Luo Y-H, Reddy A, Zhong Z, Wu J, Mammarappallil J, Healey T, Cheng G, Azzoli C, Korogodsky D, Zhang P, Feng X, Li J, Yang L, Jiao Z, Bai HX. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT. EBioMedicine. 2022 Aug;82:104127.
Journal cover image

Published In

EBioMedicine

DOI

EISSN

2352-3964

Publication Date

August 2022

Volume

82

Start / End Page

104127

Location

Netherlands

Related Subject Headings

  • Positron-Emission Tomography
  • Positron Emission Tomography Computed Tomography
  • Machine Learning
  • Lung Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences